1. AB1148 ECONOMIC BENEFIT FROM IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE WITH UPADACITINIB AND COMPARISONS WITH TOFACITINIB AND METHOTREXATE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Bensimon, A.; Yang, M.; Orvis, E.; Clewell, J.; Tundia, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗